BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28317195)

  • 1. Patch testing in the investigation of non-immediate cutaneous adverse drug reactions to metamizole.
    Pinho A; Santiago L; Gonçalo M
    Contact Dermatitis; 2017 Apr; 76(4):238-239. PubMed ID: 28317195
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
    Hassoun-Kheir N; Bergman R; Weltfriend S
    Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple cutaneous sensitization to nonsteroidal anti-inflammatory drugs.
    Gonzalo MA; Revenga F
    Dermatology; 1996; 193(1):59-60. PubMed ID: 8864624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metamizole-induced acute generalized exanthematous pustulosis.
    Gonzalo-Garijo MA; Pérez-Calderón R; De Argila D; Rodríguez-Nevado I
    Contact Dermatitis; 2003 Jul; 49(1):47-8. PubMed ID: 14641128
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of patch test in fixed drug eruption due to metamizole (Nolotil).
    Dalmau J; Serra-Baldrich E; Roé E; Peramiquel L; Alomar A
    Contact Dermatitis; 2006 Feb; 54(2):127-8. PubMed ID: 16487292
    [No Abstract]   [Full Text] [Related]  

  • 6. Occupational allergic contact dermatitis caused by antibiotics in healthcare workers - relationship with non-immediate drug eruptions.
    Pinheiro V; Pestana C; Pinho A; Antunes I; Gonçalo M
    Contact Dermatitis; 2018 Apr; 78(4):281-286. PubMed ID: 29399806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of intradermal test and patch test in the diagnosis of nonimmediate reactions to metamizol.
    Macías E; Ruiz A; Moreno E; Laffond E; Dávila I; Lorente F
    Allergy; 2007 Dec; 62(12):1462-4. PubMed ID: 17983381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic contact dermatitis to topical preparations of bufexamac.
    Pan Y; Nixon R
    Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple fixed drug eruption due to intradermal test with metamizole.
    Vidal C; González-Quintela A
    Allergy; 2007 Jun; 62(6):712-3. PubMed ID: 17508979
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated-type Reactions to High Parenteral Doses of Metamizole in Patients Who Tolerated Therapeutic Doses of Oral Metamizole and Other NSAIDs.
    Prados M; Labella M; Baynova K
    J Investig Allergol Clin Immunol; 2016; 26(6):378-379. PubMed ID: 27996946
    [No Abstract]   [Full Text] [Related]  

  • 11. [The fixed drug eruption due to metamizole].
    Sempere Verdú E; Sorando Serra R; Bayón Rueda A; Ortiz Sidera M
    Aten Primaria; 1999 Sep; 24(5):304-5. PubMed ID: 10590566
    [No Abstract]   [Full Text] [Related]  

  • 12. Metamizol as a cause of postoperative erythroderma.
    Bernedo N; Audicana MT; Uriel O; Velasco M; Gastaminza G; Fernández E; Muñoz D
    Contact Dermatitis; 2004 May; 50(5):317-8. PubMed ID: 15209816
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized reaction after patch testing with metamizol.
    Gonzalo-Garijo MA; de Argila D; Rodríguez-Nevado I
    Contact Dermatitis; 2001 Sep; 45(3):180. PubMed ID: 11553155
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined immediate- and delayed-type hypersensitivity to metamizole.
    Bellegrandi S; Rosso R; Mattiacci G; Zaffiro A; Di Sora F; Menzella F; Aiuti F; Paganelli R
    Allergy; 1999 Jan; 54(1):88-90. PubMed ID: 10195371
    [No Abstract]   [Full Text] [Related]  

  • 15. Allergic Reactions to Metamizole: Immediate and Delayed Responses.
    Blanca-López N; Pérez-Sánchez N; Agúndez JA; García-Martin E; Torres MJ; Cornejo-García JA; Perkins JR; Miranda MA; Andreu I; Mayorga C; Canto G; Blanca M; Doña I
    Int Arch Allergy Immunol; 2016; 169(4):223-30. PubMed ID: 27224978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing.
    Zedlitz S; Linzbach L; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2002 Jun; 46(6):352-3. PubMed ID: 12190624
    [No Abstract]   [Full Text] [Related]  

  • 17. Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test.
    Jaeger C; Jappe U
    Contact Dermatitis; 2005 Jan; 52(1):47-8. PubMed ID: 15701133
    [No Abstract]   [Full Text] [Related]  

  • 18. Allergic contact dermatitis from indomethacin.
    Pulido Z; González E; Alfaya T; Alvarez JA; Ceña M; de la Hoz B
    Contact Dermatitis; 1999 Aug; 41(2):112. PubMed ID: 10445701
    [No Abstract]   [Full Text] [Related]  

  • 19. Metamizole-induced reactions as a paradigm of drug hypersensitivity: Non-allergic reactions, anaphylaxis, and delayed-type allergy.
    Trautmann A; Brockow K; Stoevesandt J
    Clin Exp Allergy; 2020 Sep; 50(9):1103-1106. PubMed ID: 32564452
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
    Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
    Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.